Zydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 ...

Eluxadoline tablets will be produced at Zydus Lifesciences Ltd (SEZ) in Ahmedabad, the company said in an exchange filing.

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...

Indian equity indices ended strong on Friday, with the NIFTY closing at 23,350.40, up 159.75 points (0.69%), while the Sensex ...

Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture ...

The uptick in the Zydus Life shares came after the company received final approval from the USFDA to manufacture Eluxadoline ...

Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive ...

On Monday, 1608 stocks advanced, 2503 declined and 130 remained unchanged on Bombay Stock Exchange with advance decline ratio ...

The NSE Nifty 50 ended 0.33% lower at 22,397.20, while the BSE Sensex closed 0.27% down at 73,828.9 on Thursday.

Tata Communications, Signature Global, Power Grid, GR Infraprojects, Welspun Specialty, and Kolte Patil are among the top ...